Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-0926-2014

The Rotoprone therapy System is an advanced patient care system for the treatment and prevention of pulmonary complications. The Rotoprone Therapy System provides up to 62 degrees in both prone and supine positions as well as Trendelenburg/Reverse Trendelenburg positioning. Product Usage: Use of the Rotoprone Therapy System is indicated for patients with severe acute respiratory distress syndrome (ARDS). These are critical patients who are at higher risk of cardiac arrest and mortality. Placing a patient in the prone position may reopen collapsed airways and thus improve pulmonary gas exchange and respiratory mechanics.

Publicado el 12 de febrero de 2014 · Inicio del retiro: 11 de septiembre de 2013

Resumen

FDA registra el retiro Z-0926-2014 de dispositivos médicos de Clase II, publicado el 12 de febrero de 2014 e iniciado el 11 de septiembre de 2013. Empresa responsable: ArjoHuntleigh Inc.; Estado: Finalizado; Cantidad reportada: 231 units; Lote: Model #209500. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

The lock pin can become stuck in the "in" position during the manual rotation, resulting in the inability to prone a patient

Qué hacer

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
ArjoHuntleigh Inc.
Distribuidor
US Nationwide and Middle East
Lote
Model #209500
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿The Rotoprone therapy System is an advanced patient care system for the treatment and prevention of pulmonary complications. The Rotoprone Therapy System provides up to 62 degrees in both prone and supine positions as well as Trendelenburg/Reverse Trendelenburg positioning. Product Usage: Use of the Rotoprone Therapy System is indicated for patients with severe acute respiratory distress syndrome (ARDS). These are critical patients who are at higher risk of cardiac arrest and mortality. Placing a patient in the prone position may reopen collapsed airways and thus improve pulmonary gas exchange and respiratory mechanics. fue retirado del mercado?

Sí. FDA publicó el retiro Z-0926-2014 el 12 de febrero de 2014. Peligro reportado: The lock pin can become stuck in the "in" position during the manual rotation, resulting in the inability to prone a patient

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit